Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice

被引:78
作者
Srivastava, Rai Ajit K.
Jahagirdar, Ravi
Azhar, Salman
Sharma, Somesh
Bisgaier, Charles L.
机构
[1] CloneGen Biotechnol, Ann Arbor, MI USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[3] Esper Therapeut, Ann Arbor, MI USA
关键词
metabolic syndrome X; obesity; PPAR; diabetes; atherosclerosis; LDL receptor knock out; fenofibrate; lipogenesis; VCAM-1;
D O I
10.1007/s11010-005-9053-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fenofibrate, a selective (1)PPAR-alpha activator, is prescribed to treat human dyslipidemia. The aim of this study was to delineate the mechanism of fenofibrate-mediated reductions in adiposity, improvements in insulin sensitivity, and lowering of triglycerides (TG) and free fatty acids (FFA) and to investigate if these favorable changes are related to the inhibition of lipid deposition in the aorta. To test this hypothesis we used male LDLr deficient mice that exhibit the clinical features of metabolic syndrome X when fed a high fat high cholesterol (HF) diet. LDLr deficient mice fed HF diet and simultaneously treated with fenofibrate (100 mg/kg body weight) prevented development of obesity, lowered serum triglycerides and cholesterol, improved insulin sensitivity, and prevented accumulation of lipids in the aorta. Lowering of circulating lipids occurred via down-regulation of lipogenic genes, including fatty acid synthase, acetyl CoA carboxylase and diacyl glycerol acyl transferase-2, concomitant with decreased liver TG and cholesterol, and TG output rate. Fenofibrate also suppressed liver apoCIII mRNA levels and markedly increased lipoprotein lipase mRNA levels, known to enhance serum TG catabolism. In addition, fenofibrate profoundly reduced epididymal fat and mesenteric fat mass to the levels seen in lean mice. The reductions in body weight were associated with elevation of hepatic uncoupling protein 2 (UCP2) mRNA, a concomitant increase in the ketone body formation, and improved insulin sensitivity associated with tumor necrosis factor-alpha reductions and phosphoenol pyruvate carboxykinase down-regulation. These results demonstrate that fenofibrate improves lipid abnormalities partly via inhibition of TG production and partly via clearance of TG-rich apoB particles by elevating LPL and reduced apoCIII. The prevention of obesity development occurred via energy expenditure. Fenofibrate-mediated hypolipidemic effects together with improved insulin sensitivity and loss of adiposity led to the reductions in the aortic lipid deposition by inhibiting early stages of atherosclerosis possibly via vascular cell adhesion molecule-1 (VCAM-1) modulation. These results suggest that potent PPAR-alpha activators may be useful in the treatment of syndrome X.
引用
收藏
页码:35 / 50
页数:16
相关论文
共 58 条
[1]   MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].
AALTOSETALA, K ;
FISHER, EA ;
CHEN, XL ;
CHAJEKSHAUL, T ;
HAYEK, T ;
ZECHNER, R ;
WALSH, A ;
RAMAKRISHNAN, R ;
GINSBERG, HN ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900
[2]   Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance [J].
Adeli, K ;
Taghibiglou, C ;
Van Iderstine, SC ;
Lewis, GF .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :170-176
[3]  
Bisgaier CL, 1998, J LIPID RES, V39, P17
[4]   Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice [J].
Branén, L ;
Hovgaard, L ;
Nitulescu, M ;
Bengtsson, E ;
Nilsson, J ;
Jovinge, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :2137-2142
[5]  
Candido Riccardo, 2003, Curr Opin Investig Drugs, V4, P1088
[6]   Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members [J].
Cases, S ;
Stone, SJ ;
Zhou, P ;
Yen, E ;
Tow, B ;
Lardizabal, KD ;
Voelker, T ;
Farese, RV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :38870-38876
[7]   Flavones mitigate tumor necrosis factor-α-induced adhesion molecule -: Upregulation in cultured human endothelial cells:: Role of nuclear factor-κB [J].
Choi, JS ;
Choi, YJ ;
Park, SH ;
Kang, JS ;
Kang, YH .
JOURNAL OF NUTRITION, 2004, 134 (05) :1013-1019
[8]   A major role for VCAM-1, but not ICAM-1, in early atherosclerosis [J].
Cybulsky, MI ;
Iiyama, K ;
Li, HM ;
Zhu, SN ;
Chen, M ;
Iiyama, M ;
Davis, V ;
Gutierrez-Ramos, JC ;
Connelly, PW ;
Milstone, DS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) :1255-1262
[9]   Substance P: Structure, function, and therapeutics [J].
Datar, P ;
Srivastava, S ;
Coutinho, E ;
Govil, G .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (01) :75-103
[10]   Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice [J].
Duez, H ;
Chao, YS ;
Hernandez, M ;
Torpier, G ;
Poulain, P ;
Mundt, S ;
Mallat, Z ;
Teissier, E ;
Burton, CA ;
Tedgui, A ;
Fruchart, JC ;
Fiévet, C ;
Wright, SD ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48051-48057